This company has been marked as potentially delisted and may not be actively trading. Bioanalytical Systems (BASI) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock BASI vs. LUNA, AIKI, DKDCA, TCRX, CTSO, ZYXI, CLYM, MGNX, CABA, and VNRXShould you be buying Bioanalytical Systems stock or one of its competitors? The main competitors of Bioanalytical Systems include Luna Innovations (LUNA), AIkido Pharma (AIKI), Data Knights Acquisition (DKDCA), TScan Therapeutics (TCRX), Cytosorbents (CTSO), Zynex (ZYXI), Climb Bio (CLYM), MacroGenics (MGNX), Cabaletta Bio (CABA), and VolitionRx (VNRX). Bioanalytical Systems vs. Its Competitors Luna Innovations AIkido Pharma Data Knights Acquisition TScan Therapeutics Cytosorbents Zynex Climb Bio MacroGenics Cabaletta Bio VolitionRx Luna Innovations (NASDAQ:LUNA) and Bioanalytical Systems (NASDAQ:BASI) are both small-cap commercial physical research industry companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings. Does the media prefer LUNA or BASI? In the previous week, Luna Innovations had 12 more articles in the media than Bioanalytical Systems. MarketBeat recorded 12 mentions for Luna Innovations and 0 mentions for Bioanalytical Systems. Luna Innovations' average media sentiment score of 0.37 beat Bioanalytical Systems' score of 0.00 indicating that Luna Innovations is being referred to more favorably in the media. Company Overall Sentiment Luna Innovations Neutral Bioanalytical Systems Neutral Which has more volatility & risk, LUNA or BASI? Luna Innovations has a beta of 1.88, indicating that its stock price is 88% more volatile than the S&P 500. Comparatively, Bioanalytical Systems has a beta of 1.92, indicating that its stock price is 92% more volatile than the S&P 500. Do insiders and institutionals believe in LUNA or BASI? 87.5% of Luna Innovations shares are owned by institutional investors. Comparatively, 10.6% of Bioanalytical Systems shares are owned by institutional investors. 7.6% of Luna Innovations shares are owned by insiders. Comparatively, 11.5% of Bioanalytical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is LUNA or BASI more profitable? Luna Innovations has a net margin of 0.00% compared to Bioanalytical Systems' net margin of -7.75%. Luna Innovations' return on equity of 0.00% beat Bioanalytical Systems' return on equity.Company Net Margins Return on Equity Return on Assets Luna InnovationsN/A N/A N/A Bioanalytical Systems -7.75%-42.74%-6.38% Which has higher earnings & valuation, LUNA or BASI? Luna Innovations has higher revenue and earnings than Bioanalytical Systems. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLuna Innovations$116.61M0.28$9.28MN/AN/ABioanalytical Systems$60.47M0.37-$4.68M-$0.35-5.79 SummaryLuna Innovations beats Bioanalytical Systems on 8 of the 11 factors compared between the two stocks. Get Bioanalytical Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for BASI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BASI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BASI vs. The Competition Export to ExcelMetricBioanalytical SystemsCommercial Physical Research IndustryMedical SectorNASDAQ ExchangeMarket Cap$22.54M$20.33M$5.54B$8.96BDividend YieldN/AN/A5.38%4.08%P/E Ratio-4.82N/A19.2119.61Price / Sales0.371,439.95421.06119.62Price / Cash558.4057.2336.6357.47Price / Book2.930.278.085.67Net Income-$4.68M-$525K$3.16B$248.47M Bioanalytical Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BASIBioanalytical SystemsN/A$2.03+7.7%N/A+16.8%$22.54M$60.47M-4.82397High Trading VolumeLUNALuna Innovations0.2817 of 5 stars$0.90+1.7%N/A-69.5%$30.56M$116.61M0.00390Trending NewsGap DownAIKIAIkido PharmaN/A$5.44-2.0%N/A+165.3%$29.84M$10K-1.404DKDCAData Knights AcquisitionN/A$0.52-1.4%N/A-47.6%$2.66MN/A-2.712High Trading VolumeTCRXTScan Therapeutics2.1719 of 5 stars$1.43-1.4%$7.80+445.5%-74.3%$80.92M$2.82M-1.31100Positive NewsCTSOCytosorbents1.8312 of 5 stars$1.29+0.8%$5.50+326.4%+21.7%$80.77M$35.60M-4.61220News CoverageZYXIZynex2.6496 of 5 stars$2.66+3.1%$6.00+125.6%-70.3%$80.44M$192.35M-11.08770News CoverageAnalyst ForecastGap DownCLYMClimb Bio2.8378 of 5 stars$1.19-4.0%$9.00+656.3%N/A$80.42MN/A-0.509News CoverageMGNXMacroGenics4.124 of 5 stars$1.26+4.1%$5.71+353.5%-66.3%$79.49M$149.96M-1.42430CABACabaletta Bio1.7104 of 5 stars$1.56+2.6%$14.43+824.9%-78.3%$79.15MN/A-0.6150VNRXVolitionRx1.6996 of 5 stars$0.77+1.0%$3.50+355.8%+19.3%$79.11M$1.31M-2.1380 Related Companies and Tools Related Companies Luna Innovations Competitors AIkido Pharma Competitors Data Knights Acquisition Competitors TScan Therapeutics Competitors Cytosorbents Competitors Zynex Competitors Climb Bio Competitors MacroGenics Competitors Cabaletta Bio Competitors VolitionRx Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BASI) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioanalytical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioanalytical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
